- Lobbying
- roche AND diagnostics
Lobbying Arrangements Results for 'Roche Diagnostics'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Medicaid, Diagnostics, and general healthcare |
Roche Diagnostics Corporation
|
Krieg DeVault LLP | |||
Details Issues related to competitive bidding for DME (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) |
Roche Diagnostics Corporation
|
in-house lobbying | |||
Details Help reauthorize and appropriate the PEPFAR program. Support authorization and appropriations of PEPFAR. |
Roche Diagnostics Corporation
|
ROSEWOOD GLOBAL ADVISORS, LLC | |||
Details TESTs Act, other legislation to encourage support for testing, increase stockpile for testing equipment, VALID Act, SALSA Act |
Roche Diagnostics Corporation
|
MR. RICHARD GOODSTEIN | |||
Details Durable medical equipment |
Roche Diagnostics Corporation
pharmaceutical company |
The Walter Group | |||
Details Medicare & Medicaid issues |
Roche Diagnostics
|
DS2 Group, LLC | |||
Details Issues related to VA standardization of blood glucose testing equipment and supplies |
Roche Diagnostics, Inc.
|
B & D CONSULTING | |||
Details H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 related to competitive bidding of diabetes equipment |
Roche Diagnostics
|
SONNENSCHEIN NATH & ROSENTHAL LLP | |||
Details CMS implementation of the Competitive Acquisition Program for Durable Medical Equipment. Medicare Improvements for Patients and Providers Act of 2008. |
ROCHE DIAGNOSTICS
|
ALSTON & BIRD, LLP | |||
Details The VALID Act; HR 8188 Saving Access to Laboratory Services Act |
Roche Diagnostics
|
DS2 Group, LLC | |||
Details Issues related to Federal position on mold testing. |
Roche Diagnostics
|
PATTON BOGGS LLP | |||
Details Issues related to Medicare coverage policy for blood glucose monitors and test strips. |
Roche Diagnostics
|
Thorn Run Partners | |||
Details Supporting federal efforts on HPV care and diagnostics |
Roche Diagnostics
|
M.J. Simon & Company, LLC | |||
Details Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023. S.1000/H.R.2377-Saving Access to Laborat... |
Hooper,Lundy& Bookman, PC (obo Roche Diagnostics)
|
GOVERNMENT COUNSEL, LLC | |||
Details The Verifying Accurate Leading-edge IVCT Development Act. |
Hooper, Lundy & Bookman, P.C. (obo Roche Diagnostics)
|
Brown Rudnick LLP | |||
Details Medical diagnostic products and services. |
Diagnostic Test Work Group (DTWG)
|
Leavitt Partners, LLC | |||
Details Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act. H.R.2617, the Consolidated Appropriations Act, 2023 |
Roche Diagnostics Corporation, Inc.
|
McDermott+Consulting LLC | |||
Details Clinical Laboratories Improvement Act (CLIA) |
Roche Diagnostics Operations, Inc.
medical device |
Epstein Becker & Green PC | |||
Details (HCR) H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R. 3795 The... |
F. Hoffmann-La Roche Ltd, and Its Affiliates
|
in-house lobbying | |||
Details Clinical Laboratories Improvement ACT (CLIA) |
ROCHE DIAGNOSTICS OPERATION, INC.
|
EPSTEIN BECKER & GREEN, P.C. | |||
Details Issues related to Medicare coverage policy for blood glucose monitors and test strips. |
Roche Diagnostics
Medical device manufacturer |
Federalist Group, An Ogilvy PR Worldwide Company | |||
Details Medicare durable medical equipment reimbursement and policy Medicare laboratory reimbursement and policy, including provisions in: H.R. 1321/S. 2404, the Medicare Advanced Laboratory Diagnostics A... |
ROCHE DIAGNOSTICS CORPORATION
|
KING & SPALDING LLP | |||
Details Advocacy on Medicare reimbursement codes and payment rates for qualitative drug screen testing |
Drugs of Abuse Testing Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details Seeking Medicare coverage and reimbursement for home anticoagulation services |
Prothrombin-time Self Testing Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details H.R.3590, Patient Protection and Affordable Care Act, H.R.3962, America's Affordable Health Choices Act of 2009; S.1679, Affordable Health Choices Act; America's Healthy Future Act of 2009; Issues ... |
ROCHE DIAGNOSTICS CORPORATION
|
Ogilvy Government Relations | |||
Details Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions ... |
Genentech USA, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Yea... |
Roche Diagnostics Corporation
|
Hooper, Lundy & Bookman, P.C. | |||
Details Medicare competitive bidding program for durable medical equipment and supplies. Medicare payments for laboratory services. |
Roche Diagnostics Corporation, Inc.
|
MCDERMOTT WILL & EMERY LLP | |||
Details Medicare Durable Medical Equipment, Prosthetics, Orthodics and Supplies Competitive Bidding Program |
Diabetes Access to Care Coalition
|
McDermott+Consulting LLC | |||
Details H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017;S. 1914 - Protecting Access to Diabetes Supplies Act of 2017;Yet to be introduced House proposal for a regulatory framework fo... |
Roche Diagnostics Corporation
|
Brown Rudnick LLP | |||
Details biothreat detection |
Idaho Technology, Inc.
|
in-house lobbying | |||
Details Medicare reimbursement and coverage policy applicable to home anticoagulation monitoring services. |
Prothrombin-time Self Testing Coalition
|
McDermott+Consulting LLC | |||
Details Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program Issues H.R. 3590 Patient Protection and Affordable Care Act- H.R. 616 Pharmacists Exemption to CMS DME R... |
Diabetes Access to Care Coalition (DACC)
|
WINNING STRATEGIES WASHINGTON | |||
Details Seeking Medicare reimbursement incentives to encourage point-of-care diagnostic testing capacity. |
High-throughput Diagnostic Testing Coalition
|
McDermott+Consulting LLC | |||
Details Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies S. 1895 (Lower Health Care Costs Act), Section 401, regarding hospital billi... |
Foundation Medicine, Inc.
|
Arent Fox LLP | |||
Details Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program. |
Diabetes Access to Care Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details CMS implementation of the Competitive Acquisition Program for Durable Medical Equipment. Medicare Improvements for Patients and Providers Act. |
Abbott Laboratories
Health Care |
ALSTON & BIRD, LLP | |||
Details - Diagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2023 (H.R.2369) and the pilot program for Oncology Drug Products Used with Certain In Vitro Di... |
Foundation Medicine, Inc.
|
in-house lobbying | |||
Details Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy American Health Choices Act of 2009 H.R. 3200 American Health Choices Act of 2009 Tri C... |
Winning Strategies Washington, LLC
|
PODESTA GROUP, INC. | |||
Details Issues related to FDA and HHS program funding for the FY24 Labor, HHS, Education and Related Agencies, and FY24 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies... |
GENENTECH, INC
|
in-house lobbying |